SNM heads to Toronto for 56th Annual Meeting

March 04, 2009

Reston, Va.--SNM recently received a warm greeting as it prepares to head north to Canada for its 56th Annual Meeting for nuclear medicine and molecular imaging.

In a letter welcoming SNM to Canada later this year, Prime Minister Stephen Harper, PC, MP, stated his belief that the importance of molecular imaging to the future practice of medicine is undeniable. "It is heartening to know that your efforts are paving the way for a more effective and efficient level of patient care," he said.

For instance, more than 20 million people require molecular imaging or nuclear medicine procedures each year. These procedures include PET/CT scans--commonly used to diagnose and monitor treatment in patients with cancer, and neurological and cardiovascular diseases, including Alzheimer's disease, stroke, and cardiac events. The prime minister expressed his pleasure at serving as the host country for an event focused on molecular imaging and therapy that "gives researchers and practitioners a forum in which to exchange information about the newest and most promising advances in the field."

Toronto Mayor David Miller welcomed SNM to his city, acknowledging SNM's international reputation as a leader in nuclear medicine and molecular imaging and the annual meeting as "an important opportunity for professionals in the medical field to meet and discuss research and current trends, as well as network with friends and colleagues."

Mayor Miller added that, as home to the Discovery District--a research park with Canada's largest concentration of research institutes and business support services, as well as world-renowned medical researchers--Toronto is an excellent host city for such a meeting.
SNM's Annual Meeting is the world's largest event focused exclusively on the latest developments in molecular imaging. More than 6,000 attendees from around the world will share research, learn about the latest breakthroughs and trends, and discuss important issues in the field that have been making news. More than 180 exhibiting companies will take part in the premier conference.

Society of Nuclear Medicine

Related Molecular Imaging Articles from Brightsurf:

New technique offers higher resolution molecular imaging and analysis
The new approach from Northwestern Engineering could help researchers understand more complicated biomolecular interactions and characterize cells and diseases at the single-molecule level.

Molecular imaging offers insight into therapy outcomes for neuroendocrine tumor patients
A new proof-of-concept study published in the May issue of The Journal of Nuclear Medicine has demonstrated that molecular imaging can be used for identifying early response to 177Lu-DOTATATE treatment in neuroendocrine tumor patients.

Non-invasive imaging method spots cancer at the molecular level
Researchers for the first time have combined a powerful microscopy technique with automated image analysis algorithms to distinguish between healthy and metastatic cancerous tissue without relying on invasive biopsies or the use of a contrast dye.

Molecular imaging suggests smokers may have impaired neuroimmune function
Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNM MI) shows preliminary evidence that tobacco smokers may have reduced neuroimmune function compared with nonsmokers.

Novel noninvasive molecular imaging for monitoring rheumatoid arthritis
A first-in-human Phase 1/Phase II study demonstrates that intravenous administration of the radiopharmaceutical imaging agent technetium-99m (99mTc) tilmanocept promises to be a safe, well-tolerated, noninvasive means of monitoring rheumatoid arthritis disease activity.

Improving molecular imaging using a deep learning approach
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed using a new deep learning approach to image reconstruction developed by researchers at Rensselaer Polytechnic Institute.

Nanoplatform developed with three molecular imaging modalities for tumor diagnosis
Nanotechnology and biotechnology are bringing us increasingly closer to personalised cancer treatment.

Study suggests molecular imaging strategy for determining molecular classifications of NSCLC
Recent findings suggest a novel positron emission tomography (PET) imaging approach determining epidermal growth factor receptor (EGFR) mutation status for improved lung cancer patient management.

New imaging technique able to watch molecular dynamics of neurodegenerative diseases
Researchers have developed a fast and practical molecular-scale imaging technique that could let scientists view never-before-seen dynamics of biological processes involved in neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis.

Combined optical and molecular imaging could guide breast-conserving surgery
Breast-conserving surgery is the primary treatment for early-stage breast cancer, but more accurate techniques are needed to assess resection margins during surgery to avoid the need for follow-up surgeries.

Read More: Molecular Imaging News and Molecular Imaging Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to